The company said that participants dosed at 25 or 100 micrograms achieved concentrations of neutralizing antibodies against the SARS-CoV-2 virus at levels comparable to or exceeding those of Covid-19 patients who had recovered.

LEAVE A REPLY

Please enter your comment!
Please enter your name here